97 related articles for article (PubMed ID: 28931218)
1. Aberrant Humoral Immune Responses in Neurosyphilis: CXCL13/CXCR5 Play a Pivotal Role for B-Cell Recruitment to the Cerebrospinal Fluid.
Yu Q; Cheng Y; Wang Y; Wang C; Lu H; Guan Z; Huang J; Gong W; Shi M; Ni L; Wu J; Peng R; Zhou P
J Infect Dis; 2017 Sep; 216(5):534-544. PubMed ID: 28931218
[TBL] [Abstract][Full Text] [Related]
2. CXCL13 and TH1/Th2 cytokines in the serum and cerebrospinal fluid of neurosyphilis patients.
Yan Y; Wang J; Qu B; Zhang Y; Wei Y; Liu H; Wu C
Medicine (Baltimore); 2017 Nov; 96(47):e8850. PubMed ID: 29381995
[TBL] [Abstract][Full Text] [Related]
3. CXCL13 antibody for the treatment of autoimmune disorders.
Klimatcheva E; Pandina T; Reilly C; Torno S; Bussler H; Scrivens M; Jonason A; Mallow C; Doherty M; Paris M; Smith ES; Zauderer M
BMC Immunol; 2015 Feb; 16(1):6. PubMed ID: 25879435
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid CXCL13 concentration for diagnosis and monitoring of neurosyphilis in people with HIV.
Carvalho RS; Rangel IC; Soane MM; Bacarov NBS; Herbst V; Ferry FRA
AIDS; 2024 Apr; 38(5):657-668. PubMed ID: 38079581
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid CXCL13 concentration for diagnosis of neurosyphilis: a systematic review and meta-analysis.
Du FZ; Zhang X; Zheng XL; Zhang RL; Wang QQ
BMJ Open; 2024 May; 14(5):e078527. PubMed ID: 38821573
[TBL] [Abstract][Full Text] [Related]
6. Towards a refined understanding of cerebrospinal fluid CXCL13 in neurosyphilis diagnosis among people with HIV.
de S Carvalho R; Rangel IC; Ferry FRA
AIDS; 2024 Jul; 38(8):1275-1278. PubMed ID: 38814719
[No Abstract] [Full Text] [Related]
7. CXCL13 chemokine as a promising biomarker to diagnose neurosyphilis in HIV-negative patients.
Zeng YL; Lin YQ; Zhang NN; Zou CN; Zhang HL; Peng F; Liu ZJ; Zheng WH; Yan JH; Liu LL
Springerplus; 2016; 5(1):743. PubMed ID: 27376011
[TBL] [Abstract][Full Text] [Related]
8. Alternatives to the Cerebrospinal Fluid Venereal Disease Research Laboratory Test for Neurosyphilis Diagnosis.
Marra CM
Sex Transm Dis; 2021 Aug; 48(8S):S54-S57. PubMed ID: 33967236
[TBL] [Abstract][Full Text] [Related]
9. Beyond T cell toxicity - Intrathecal chemokine CXCL13 indicating B cell involvement in immune-related adverse events following checkpoint inhibition: A two-case series and literature review.
Otto F; Seiberl M; Bieler L; Moser T; Kleindienst W; Wallner-Essl W; Koelblinger P; Wipfler P; Harrer A
Eur J Neurol; 2024 Jul; 31(7):e16279. PubMed ID: 38556899
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of the chemokine CXCL13, genetic variation in CXCL13 and its receptor CXCR5, and HIV-associated non-hodgkin B-cell lymphoma risk.
Hussain SK; Zhu W; Chang SC; Breen EC; Vendrame E; Magpantay L; Widney D; Conn D; Sehl M; Jacobson LP; Bream JH; Wolinsky S; Rinaldo CR; Ambinder RF; Detels R; Zhang ZF; Martínez-Maza O
Cancer Epidemiol Biomarkers Prev; 2013 Feb; 22(2):295-307. PubMed ID: 23250934
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal Fluid CXCL13 as Candidate Biomarker of Intrathecal Immune Activation, IgG Synthesis and Neurocognitive Impairment in People with HIV.
Trunfio M; Mighetto L; Napoli L; Atzori C; Nigra M; Guastamacchia G; Bonora S; Di Perri G; Calcagno A
J Neuroimmune Pharmacol; 2023 Jun; 18(1-2):169-182. PubMed ID: 37166552
[TBL] [Abstract][Full Text] [Related]
12. CXCL13 responsiveness but not CXCR5 expression by late transitional B cells initiates splenic white pulp formation.
Neely HR; Flajnik MF
J Immunol; 2015 Mar; 194(6):2616-23. PubMed ID: 25662995
[TBL] [Abstract][Full Text] [Related]
13. Increased interleukin-17 in peripheral blood and cerebrospinal fluid of neurosyphilis patients.
Wang C; Zhu L; Gao Z; Guan Z; Lu H; Shi M; Gao Y; Xu H; Yang XF; Zhou P
PLoS Negl Trop Dis; 2014; 8(7):e3004. PubMed ID: 25080350
[TBL] [Abstract][Full Text] [Related]
14. Further considerations on the use of cerebrospinal fluid C-X-C motif chemokine ligand 13 in the diagnosis of neurosyphilis among people with HIV.
Trunfio M; Bonora S; di Perri G; Calcagno A
AIDS; 2024 Jul; 38(8):1273-1275. PubMed ID: 38814718
[No Abstract] [Full Text] [Related]
15. CXCL13 in Cerebrospinal Fluid: Clinical Value in a Large Cross-Sectional Study.
Erhart DK; Klose V; Schäper T; Tumani H; Senel M
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203597
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of cerebrospinal fluid chemokine c-x-c motif ligand 13 for neurosyphilis: A systematic review and meta-analysis.
Luan X; Du Y; Luo D
Int J STD AIDS; 2024 Feb; 35(2):96-102. PubMed ID: 37795953
[TBL] [Abstract][Full Text] [Related]
17. The N-terminal length and side-chain composition of CXCL13 affect crystallization, structure and functional activity.
Rosenberg EM; Herrington J; Rajasekaran D; Murphy JW; Pantouris G; Lolis EJ
Acta Crystallogr D Struct Biol; 2020 Oct; 76(Pt 10):1033-1049. PubMed ID: 33021505
[TBL] [Abstract][Full Text] [Related]
18. Large-Scale Proteome Profiling Identifies Biomarkers Associated with Suspected Neurosyphilis Diagnosis.
Li J; Ma J; Liu M; Li M; Zhang M; Yin W; Wu M; Li X; Zhang Q; Zhang H; Zheng H; Mao C; Sun J; Wang W; Lyu W; Yue X; Weng W; Li J; Chen F; Zhu Y; Leng L
Adv Sci (Weinh); 2024 Apr; 11(16):e2307744. PubMed ID: 38380496
[TBL] [Abstract][Full Text] [Related]
19. Role and application of chemokine CXCL13 in central nervous system lymphoma.
Li C; Zhang L; Jin Q; Jiang H; Wu C
Ann Hematol; 2023 Nov; ():. PubMed ID: 38010409
[TBL] [Abstract][Full Text] [Related]
20. B cell zone reticular cell microenvironments shape CXCL13 gradient formation.
Cosgrove J; Novkovic M; Albrecht S; Pikor NB; Zhou Z; Onder L; Mörbe U; Cupovic J; Miller H; Alden K; Thuery A; O'Toole P; Pinter R; Jarrett S; Taylor E; Venetz D; Heller M; Uguccioni M; Legler DF; Lacey CJ; Coatesworth A; Polak WG; Cupedo T; Manoury B; Thelen M; Stein JV; Wolf M; Leake MC; Timmis J; Ludewig B; Coles MC
Nat Commun; 2020 Jul; 11(1):3677. PubMed ID: 32699279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
